title: Walking deficits and centrophobism in an α-synuclein fly model of Parkinson's disease.
abstract: Parkinson's disease (PD) is a movement neurodegenerative disorder, characterized by bradykinesia, rigidity and tremor, constituting difficulties in walking and abnormal gait. Previous research shows that Drosophila expressing human α-synuclein A30P (A30P) develop deficits in geotaxis climbing; however, geotaxis climbing is a different movement modality from walking. Whether A30P flies would exhibit abnormal walking in a horizontal plane, a measure more relevant to PD, is not known. In this study, we characterized A30P fly walking using a high-speed camera and an automatic behavior tracking system. We found that old but not young A30P flies exhibited walking abnormalities, specifically decreased total moving distance, distance per movement, velocity, angular velocity and others, compared with old control flies. Those features match the definition of bradykinesia. Multivariate analysis further suggested a synergistic effect of aging and A30P, resulting in a distinct pattern of walking deficits, as seen in aged A30P flies. Psychiatric problems are common in PD patients with anxiety affecting 40-69% of patients. Central avoidance is one assessment of anxiety in various animal models. We found old but not young A30P flies exhibited increased centrophobism, suggesting possible elevated anxiety. Here, we report the first quantitative measures of walking qualities in a PD fly model and propose an alternative behavior paradigm for evaluating motor functions apart from climbing assay.
authors.affiliation: Dart Neuroscience LLC, San Diego, CA; Cold Spring Harbor Laboratory, Cold Spring Harbor, Stony Brook, NY; Graduate Program in Neuroscience, SUNY Stony Brook, Stony Brook, NY.
authors.forename: A Y
authors.initials: AY
authors.lastname: Chen
authors.forename: P
authors.initials: P
authors.lastname: Wilburn
authors.forename: X
authors.initials: X
authors.lastname: Hao
authors.forename: T
authors.initials: T
authors.lastname: Tully
mesh_terms: D000367:Age Factors; D000818:Animals; D004195:Disease Models, Animal; D004330:Drosophila; D008124:Locomotion / Q000235:genetics*; D009043:Motor Activity / Q000235:genetics*; D010300:Parkinson Disease / Q000235:genetics* / Q000503:physiopathology; D016138:Walking / Q000502:physiology*; D051844:alpha-Synuclein / Q000235:genetics*
chemical_list: D051844:alpha-Synuclein
keywords: A30P; Drosophila; Parkinson's disease; bradykinesia; centrophobism; multivariate analysis; neurodegenerative diseases; open field; walking deficits; α-synuclein
references.citation: Mov Disord. 2000 Jul;15(4):669-77
references.pmid: 10928577
references.citation: Neurobiol Dis. 2008 Apr;30(1):65-73
references.pmid: 18243716
references.citation: Learn Mem. 1998 May-Jun;5(1-2):38-51
references.pmid: 10454371
references.citation: Nat Neurosci. 2005 May;8(5):657-63
references.pmid: 15834418
references.citation: BMC Genomics. 2005 Sep 21;6:134
references.pmid: 16176584
references.citation: Genesis. 2011 May;49(5):392-402
references.pmid: 21584925
references.citation: Curr Biol. 2012 Nov 20;22(22):2114-23
references.pmid: 23022067
references.citation: J Neurogenet. 2009;23(1-2):173-84
references.pmid: 19145515
references.citation: PLoS One. 2014 May 30;9(5):e97758
references.pmid: 24879013
references.citation: Mov Disord. 2003 Jun;18(6):646-51
references.pmid: 12784267
references.citation: Science. 1997 Jun 27;276(5321):2045-7
references.pmid: 9197268
references.citation: Annu Rev Genet. 2005;39:153-71
references.pmid: 16285856
references.citation: J Neurogenet. 2009;23(1-2):225-34
references.pmid: 19306211
references.citation: Minerva Med. 2005 Jun;96(3):155-73
references.pmid: 16175159
references.citation: Trends Pharmacol Sci. 2008 Oct;29(10):493-8
references.pmid: 18755516
references.citation: Behav Processes. 2004 Sep 30;67(2):207-19
references.pmid: 15240058
references.citation: Sci Am. 1973 Dec;229(6):24-37
references.pmid: 4202065
references.citation: Science. 2003 Oct 31;302(5646):841
references.pmid: 14593171
references.citation: J Neurogenet. 2001;15(3-4):205-19
references.pmid: 12092904
references.citation: J Neurosci. 1993 May;13(5):1852-61
references.pmid: 8478679
references.citation: Exp Neurol. 2008 Apr;210(2):788-92
references.pmid: 18295208
references.citation: Proc Natl Acad Sci U S A. 2005 May 31;102(22):8024-9
references.pmid: 15911761
references.citation: Nat Med. 2001 Mar;7(3):297-303
references.pmid: 11231627
references.citation: Nat Genet. 1998 Feb;18(2):106-8
references.pmid: 9462735
references.citation: J Neurobiol. 2005 Feb 15;62(3):386-96
references.pmid: 15547935
references.citation: Nat Rev Neurosci. 2003 Sep;4(9):727-38
references.pmid: 12951565
references.citation: J Neurosci. 2004 Nov 24;24(47):10584-93
references.pmid: 15564574
references.citation: Semin Clin Neuropsychiatry. 1996 Oct;1(4):241-247
references.pmid: 10320427
references.citation: Ann Neurol. 2004 Feb;55(2):164-73
references.pmid: 14755719
references.citation: Front Neural Circuits. 2009 Jul 01;3:5
references.pmid: 19597562
references.citation: J Comp Physiol A. 1999 Sep;185(3):277-88
references.pmid: 10573866
references.citation: Mov Disord. 2012 Apr;27(4):492-9
references.pmid: 21997389
references.citation: J Neurosci. 2008 Jan 9;28(2):465-72
references.pmid: 18184789
references.citation: Elife. 2013 Jan 08;2:e00231
references.pmid: 23326642
references.citation: Neurology. 1992 Feb;42(2):333-9
references.pmid: 1736161
references.citation: Lancet Neurol. 2011 Aug;10(8):734-44
references.pmid: 21777828
references.citation: Ann N Y Acad Sci. 1969 Jul 30;159(3):852-9
references.pmid: 5260302
references.citation: Science. 2002 Feb 1;295(5556):865-8
references.pmid: 11823645
references.citation: Mov Disord. 2008 Oct 15;23(13):1889-96
references.pmid: 18709682
references.citation: Nat Med. 2002 Nov;8(11):1185-6
references.pmid: 12411925
references.citation: Mov Disord. 2008 Oct 30;23(14):2015-25
references.pmid: 18792121
references.citation: Clin Neuropharmacol. 1998 May-Jun;21(3):159-68
references.pmid: 9617507
references.citation: J Pharmacol Exp Ther. 2002 Jan;300(1):91-6
references.pmid: 11752102
references.citation: Curr Biol. 2010 Sep 28;20(18):1602-14
references.pmid: 20832315
references.citation: Curr Biol. 2005 Apr 12;15(7):603-15
references.pmid: 15823532
references.citation: Neuropharmacology. 2009 Mar;56(3):647-52
references.pmid: 19084027
references.citation: J Neurol Neurosurg Psychiatry. 2010 May;81(5):513-8
references.pmid: 19758982
references.citation: Neurobiol Dis. 2005 Nov;20(2):303-13
references.pmid: 16242637
references.citation: Nature. 2000 Mar 23;404(6776):394-8
references.pmid: 10746727